Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si, a Connecticut-based start-up, today introduced the world’s first next-generation protein sequencing platform at Cowen Healthcare 2020. The Quantum-Si ...

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...

The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...

Bulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing strategy that works for diverse biologics modalities ...

Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...

Whether you’re interested in why a living system works as it does or the reasons it goes awry, proteins are a critical part of the molecular picture. The proteins circulating in a person’s plasma can ...

When it comes to critical care for newborns, being able to act fast is of the utmost importance, which is why this new DNA tech is so important.

The Global Targeted Sequencing Market is poised for growth due to rising demand for precise diagnostics in genetic disorders and cancer. Opportunities lie in leveraging AI for data analysis, enhancing ...